Biodesix, Inc. (BDSX)

USD 0.52

(-1.52%)

Revenue Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual revenue in 2023 was 49.08 Million USD , up 28.46% from previous year.
  • Biodesix, Inc.'s latest quarterly revenue in 2024 Q2 was 17.92 Million USD , up 20.97% from previous quarter.
  • Biodesix, Inc. reported a annual revenue of 38.21 Million USD in annual revenue 2022, down -29.89% from previous year.
  • Biodesix, Inc. reported a annual revenue of 54.5 Million USD in annual revenue 2021, up 19.64% from previous year.
  • Biodesix, Inc. reported a quarterly revenue of 14.81 Million USD for 2024 Q1, up 1.02% from previous quarter.
  • Biodesix, Inc. reported a quarterly revenue of 18.15 Million USD for 2024 Q3, up 1.26% from previous quarter.

Annual Revenue Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Revenue of Biodesix, Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 49.08 Million USD 28.46%
2022 38.21 Million USD -29.89%
2021 54.5 Million USD 19.64%
2020 45.55 Million USD 85.55%
2019 24.55 Million USD 20.16%
2018 20.43 Million USD 0.0%

Peer Revenue Comparison of Biodesix, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -57.083%
bioAffinity Technologies, Inc. 2.53 Million USD -1838.283%
Castle Biosciences, Inc. 219.78 Million USD 77.666%
DarioHealth Corp. 20.35 Million USD -141.19%
Exact Sciences Corporation 2.49 Billion USD 98.036%
IDEXX Laboratories, Inc. 3.66 Billion USD 98.659%
Illumina, Inc. 4.5 Billion USD 98.91%
Intelligent Bio Solutions Inc. 3.11 Million USD -1477.457%
iSpecimen Inc. 9.92 Million USD -394.421%
Standard BioTools Inc. 106.34 Million USD 53.84%
23andMe Holding Co. 219.63 Million USD 77.651%
Medpace Holdings, Inc. 1.88 Billion USD 97.397%
NeoGenomics, Inc. 591.64 Million USD 91.703%
Inotiv, Inc. 572.42 Million USD 91.425%
Psychemedics Corporation 22.09 Million USD -122.133%
Prenetics Global Limited 21.74 Million USD -125.763%
Precipio, Inc. 15.19 Million USD -223.005%
RadNet, Inc. 1.61 Billion USD 96.964%
Sotera Health Company 1.04 Billion USD 95.322%
Star Equity Holdings, Inc. 45.78 Million USD -7.212%
Exagen Inc. 52.54 Million USD 6.586%
Natera, Inc. 1.08 Billion USD 95.466%
Aspira Women's Health Inc. 9.15 Million USD -436.236%
Neogen Corporation 924.22 Million USD 94.689%
Myriad Genetics, Inc. 678.4 Million USD 92.764%
ICON Public Limited Company 8.12 Billion USD 99.395%
Bionano Genomics, Inc. 36.11 Million USD -35.915%
CareDx, Inc 280.32 Million USD 82.489%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 84.316%
Guardant Health, Inc. 563.94 Million USD 91.296%
BioNexus Gene Lab Corp. 9.77 Million USD -402.384%
Fulgent Genetics, Inc. 289.21 Million USD 83.027%
Sera Prognostics, Inc. 306 Thousand USD -15941.503%
OPKO Health, Inc. 863.49 Million USD 94.315%
Personalis, Inc. 73.48 Million USD 33.198%
Applied DNA Sciences, Inc. 13.36 Million USD -267.213%
Star Equity Holdings, Inc. 45.78 Million USD -7.212%
MDxHealth SA 70.19 Million USD 30.069%
Prenetics Global Limited 21.74 Million USD -125.763%
ENDRA Life Sciences Inc. - USD -Infinity%
Mainz Biomed B.V. 895.47 Thousand USD -5381.647%
Trinity Biotech plc 56.83 Million USD 13.628%
Neuronetics, Inc. 71.34 Million USD 31.201%
bioAffinity Technologies, Inc. 2.53 Million USD -1838.283%